Incidence of PDR/CSME/VH by 5 years · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Change in visual loss associated with PSR: visual loss is defined by the deterioration of visual acuity of 3 lines or more with the Snellen chart · type 1 or type 2 diabetics
It is very uncertain whether blood pressure intervention/intensive blood pressure intervention changes visual acuity (loss of 3 lines or more) by 5 years compared with placebo/standard blood pressure intervention (very low certainty).
1 finding from 1 review
Adverse events—all‐cause mortality · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Adverse events: hypotension · type 1 or type 2 diabetics
Blood pressure intervention/intensive blood pressure intervention may leads to higher adverse events—hypotension compared with placebo/standard blood pressure intervention (low certainty).
1 finding from 1 review
Improved or corrected strabismusa at 6 or 12 months · adults and children with strabismus
Botulinum toxin may leads to lower improved or corrected strabismusa at 6 or 12 months compared with surgery (low certainty).
1 finding from 1 review
Serious adverse events at 6 or 12 months · adults and children with strabismus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants requiring additional surgery(ies) at 6 or 12 months · adults and children with strabismus
It is very uncertain whether botulinum toxin changes proportion of participants requiring additional surgery(ies) at 6 or… compared with surgery (very low certainty).
1 finding from 1 review
Proportion of participants who achieved binocular single vision at 6 or 12 months · adults and children with strabismus
Botulinum toxin showed no clear difference in proportion of participants who achieved binocular single vision at 6… compared with surgery (low certainty).
1 finding from 1 review
Quality of life (validated questionnaire) · adults and children with strabismus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐serious adverse events at 6 or 12 months · adults and children with strabismus
1 finding from 1 review
Intervention not reported
Aflibercept · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Conbercept · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Bevacizumab · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Ranibizumab deferred laser · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Ranibizumab prompt laser · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Laser · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Aflibercept · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Bevacizumab · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Ranibizumab prompt laser · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Ranibizumab deferred laser · people with diabetic macular oedema
1 finding from 1 review